Cataract / Lens Implant Educational Videos

Dr. Chang is considered an authority in the field of "Refractive Intraocular Lenses (IOLs)". To help educate patients about this topic, Dr. Chang wrote the scripts and collaborated with Eyemaginations to develop a series of patient educational videos. Called the “Chang IOL Modules”, these videos are marketed through Eyemaginations and are used by physicians around the Dr. Chang donates his royalties to the humanitarian cataract charities – Project Vision and Himalayan Cataract Project.
Educational VideosDr. Chang In the News

Within ophthalmology, Dr Chang is widely considered one of the leading cataract surgeons, educators, and clinical investigators in the world. In this capacity, he has often been selected by medical associations to respond to media requests for information.
Dr. Chang In the NewsHumanitarian Cataract Surgery

Although curable with surgery, cataracts remain the leading cause of blindness in the world, accounting for more than one half of all blindness. Dr. Chang has used his international prominence to highlight and advance several important cataract efforts. He has traveled to many developing countries to perform and teach cataract surgery to local ophthalmologists.
Humanitarian Cataract SurgeryFlomax & Cataract Surgery

The intraoperative floppy iris syndrome was first reported by Drs. David Chang and John Campbell in 2005. This major discovery showed that the most common prostate medications (such as Flomax) cause iris problems during cataract surgery that can lead to many complications if the surgeon does not anticipate them. Dr. Chang has done extensive clinical research and is considered one of the world authorities on how to avoid and manage these problems.
Flomax & Cataract SurgeryOphthalmologist Information
American Academy of Ophthalmology ONE network - Chang video
Tamsulosin-intraoperative floppy iris syndrome link is urged to be considered by primary care physicians (Ophthalmology Times, August 2009)
Does Flomax Deserve a "Black Box" Warning?(Ophthalmology Management, August 2009)
Tamsulosin use linked with postop cataract surgery complications (Ocular Surgery News, July 2009)
IFIS ... in general medical journals (EyeWorld, July 2009)
Why BPH treatment can complicate cataract surgery (EyeWorld, July 2009)
ASCRS & AAO seeking to better educate prescribing physicians about IFIS (EyeWorld, July 2009)
AAO, ASCRS update advisory urging patients to disclose tamsulosin use (Ocular Surgery News, June 2009)
ASCRS IFIS white paper provides most recent information (EyeWorld, December 2008)
Severity determines intraoperative floppy iris syndrome management approach (Ophthalmology Times,November 2008)
Anticipate silodosin-IFIS link, surgeon says (Ophthalmology Times,November 2008)
Alpha-blocker, iris syndrome link still a concern (Ophthalmology Times, September 2008)
Consider cataract effects before prescribing alpha blockers (Ophthalmology Times, August 2008)
ASCRS survey shows that IFIS is still a surgical challengeworld.org/article.php (EyeWorld, July 2008)
ASCRS survey results prompt IFIS education campaign (Ocular Surgery News, July 2008)
ASCRS survey details risks of alpha-blockers, IFIS (Ocular Surgery News, July 2008)
Numerous strategies may be needed to control IFIS (Ophthalmology Times, June 2008)
Arsenal of strategies enables safe surgery in IFIS eyes (Ophthalmology Times, April 2008)
State of the art: Intraoperative floppy iris syndrome (Ocular Surgery News, March 2008)
Pearls for managing IFIS (EyeWorld Supplement September 2007)
Benedetto Strampeli Medal Lecture: Proper planning, precautions allow safe cataract surgery in IFIS case (Ocular Surgery News, May 2007)
Range of severity of IFIS requires varied management strategies (Ocular Surgery News, March 2007)
Alternative strategies successful in managing IFIS (Ophthalmology Times, February 2007)
Range of severity of IFIS requires varied management strategies (Ocular Surgery News, January 2007)
Groups issue advisory about alpha-blockers, iris syndrome (Urology Times, October 2006)
Associations advise cataract patients on risks of alpha-blockers (Ophthalmology Times, September 2006)
Two Studies Link Flomax to IFIS (Ophthalmology Management, July 2005)
Intraoperative Floppy Iris Syndrome
- Managing IFIS with iris retractors (Cataract & Refractive Surgery Today, September 2006)
- oint AAO & ASCRS Press Release (August 2006)
- American Urological Association Press Release (August 2006)
- Physician groups urge patients to disclose Flomax use to cataract surgeons (Ocular Surgery News, August 2006)
- Eye Surgeons Need Patients' Complete Drug Profiles (American Society of Health System Pharmacists, August 2006)
- Patients Still Not Getting the Message on Flomax and Cataract Surgery - Academy Member Alert
- Anticipation key to managing IFIS (Ophthalmology Times, June 2006)
- The Information Superhighway — Guest Editorial (EyeWorld, April 2006)
- Stopping the Flopping: Managing IFIS (Review of Ophthalmology, March 2006)
- The Flomaxinators take the cataract Challenge Cup (Ocular Surgery News, March 2006)
- Cataract surgery affected by tamsulosin (American Society of Health System Pharmacists, November 2005)
- Dear Doctor letter (Boehringer Ingelheim Pharmaceuticals, November 2005)
- FDA approves Flomax labeling change (Ocular Surgery News, November 2005)
- FDA Approves Label Change for Flomax Following Report of Cataract Surgery Complications (American Academy of Ophthalmology, Nov 2005)
- Eliciting tamsulosin treatment history key for predicting IFIS (Ophthalmology Times, October 2005)
- Floppy iris requires special management (Eurotimes, October 2005)
- Relatory Matters: Floppy Iris Syndrome (Eurotimes, October 2005)
- Journal of Cataract & Refractive Surgery Article (JCRS, April 2005)
- The Intraoperative Floppy Iris Syndrome (Cataract & Refractive Surgery Today, April 2005)
- Managing Floppy Iris Syndrome (Ophthalmology Management—April 2005)
- Study Will Assess Flomax and Floppy Iris (Review of Ophthalmology, March 2005)
- FDA studies intraoperative cataract complication, prostate drug (Ophthalmology Times, March 2005)
- ASCRS Team to Investigate Flomax—Urinary Drug May Cause Cataract Surgery Complication (Ophthalmology Management—March 2005)
- Beware Floppy Iris During Phaco (EyeNet, March 2005)
- ASCRS Forms Flomax Working Group (American Society of Cataract & Refractive Surgery, February 2005 )
- Perspectives in Lens & IOL Surgery Surgeons report—a new small pupil syndrome caused by Flomax (Eyeworld Magazine, January 2005)
- Flomax use in male cataract patients associated with floppy iris (Ocular Surgery News, January 2005)
- ASCRS Issues Physician Advisory on Flomax (American Society of Cataract & Refractive Surgery, January 2005 )

David F. Chang, MD is a Summa Cum Laude graduate of Harvard College and earned his M.D. at Harvard Medical School. He completed his ophthalmology residency at the University of California, San Francisco (UCSF) where he is now a clinical professor. Dr. Chang is serving a 5-year term as chairman of the American Academy of Ophthalmology (AAO) Annual Meeting Program Committee, having previously chaired the Cataract Program Sub-committee.
Dr. Chang's CV
Learn about Dr. Chang’s colaboration with Eyemaginations’ development of 3D eye animations